VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SGMO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SGMOSangamo Therapeutics, Inc.
$0.07$31M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSGMOQuarterly Financials

Sangamo Therapeutics, Inc. (SGMO) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Sangamo Therapeutics, Inc. (SGMO) quarterly income statement — complete revenue, gross profit & net income history

SGMO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue1.44M14.23M581K18.31M6.44M7.55M49.41M356K481K2.04M9.4M6.83M157.96M27.23M26.46M29.38M28.23M27.99M28.56M27.87M
Revenue Growth %-77.6%88.43%-98.82%5042.13%1238.25%269.78%425.77%-94.79%-99.7%-92.5%-64.48%-76.73%459.52%-2.7%-7.36%5.4%7.42%8.47%-50.55%29.32%
Cost of Goods Sold000000000057.09M59.25M63.22M66.18M65.12M60.02M58.58M51.8M62.5M60.09M
COGS % of Revenue----------607.46%866.8%40.02%243.04%246.09%204.3%207.52%185.1%218.81%215.58%
Gross Profit1.44M14.23M581K18.31M6.44M7.55M49.41M356K481K2.04M-47.69M-52.41M94.74M-38.95M-38.66M-30.64M-30.35M-23.82M-33.94M-32.21M
Gross Margin %100%100%100%100%100%100%100%100%100%100%-507.46%-766.8%59.98%-143.04%-146.09%-104.3%-107.52%-85.1%-118.81%-115.58%
Gross Profit Growth %-77.6%88.43%-98.82%5042.13%1238.25%269.78%203.61%100.68%-99.49%105.24%-23.37%-71.05%412.13%-63.55%-13.91%4.88%-0.66%10.33%-372%-61.31%
Operating Expenses33.39M39.2M36.13M36.16M36.06M33.54M38.78M37.44M52.01M64.1M58.72M71.16M76.71M16.44M16.24M15.09M14.91M16.08M14.5M16.49M
OpEx % of Revenue2315.4%275.48%6219.28%197.54%560.28%444.19%78.48%10516.85%10812.27%3139.13%624.78%1041.13%48.56%60.39%61.37%51.38%52.81%57.47%50.77%59.15%
Selling, General & Admin6.82M7.76M7.99M9.08M10.06M9.87M11.05M12.04M11.77M13.1M13.92M14.81M18.14M16.44M16.24M15.09M14.91M16.08M14.5M16.49M
SG&A % of Revenue472.82%54.53%1375.56%49.58%156.27%130.66%22.36%3383.43%2446.36%641.48%148.1%216.74%11.48%60.39%61.37%51.38%52.81%57.47%50.77%59.15%
Research & Development26.57M31.44M28.14M27.08M26.01M23.68M27.73M24.22M35.89M50.71M57.09M63.05M63.22M66.18M65.12M60.02M58.58M51.8M62.5M60.09M
R&D % of Revenue1842.58%220.96%4843.72%147.95%404.01%313.53%56.12%6804.21%7461.75%2483.15%607.46%922.4%40.02%243.04%246.09%204.3%207.52%185.1%218.81%215.58%
Other Operating Expenses00000001000K1000K296K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-31.95M-24.97M-35.55M-17.86M-29.63M-25.99M10.63M-37.08M-51.53M-62.06M-106.41M-123.57M18.03M-55.39M-54.89M-45.73M-45.26M-39.9M-48.44M-48.7M
Operating Margin %-2215.4%-175.49%-6119.28%-97.54%-460.28%-344.19%21.52%-10416.85%-10712.27%-3039.13%-1132.24%-1807.93%11.42%-203.42%-207.46%-155.67%-160.32%-142.57%-169.58%-174.73%
Operating Income Growth %-7.82%3.93%-434.43%51.85%42.5%58.12%109.99%69.99%-385.72%-12.04%-93.84%-170.2%139.84%-38.83%-13.33%6.09%2.25%8.13%-1208.73%-28.51%
EBITDA-31.07M-23.09M-33.66M-15.96M-27.7M-23.86M12.76M-34.51M-49M-59.05M-100.92M-119.32M21.52M-52.05M-51.84M-42.85M-42.43M-37.13M-45.88M-46.45M
EBITDA Margin %-2154.58%-162.25%-5792.6%-87.17%-430.39%-315.92%25.82%-9694.1%-10187.11%-2891.77%-1073.79%-1745.66%13.63%-191.15%-195.94%-145.86%-150.29%-132.69%-160.63%-166.67%
EBITDA Growth %-12.15%3.23%-363.8%53.76%43.46%59.6%112.64%71.08%-327.66%-13.45%-94.65%-178.45%150.73%-40.16%-13%7.76%4.5%11.05%-1859.89%-27.03%
D&A (Non-Cash Add-back)877K1.88M1.9M1.9M1.92M2.13M2.13M2.57M2.53M3.01M5.49M4.26M3.49M3.34M3.05M2.88M2.83M2.76M2.56M2.25M
EBIT-31.95M-24.97M-35.09M-19.96M-29.63M-25.99M10.63M-35.91M-47.18M-61.76M-61.61M-67.22M76.61M-55.39M-54.89M-45.73M-45.26M-39.9M-48.44M-48.7M
Net Interest Income300K252K355K386K309K2.17M129K1.03M451K1.49M3.52M2.8M3.29M3.68M1.77M2.64M1.34M2.34M834K1.55M
Interest Income300K252K355K386K309K2.17M129K1.03M451K1.49M3.52M2.8M3.29M3.68M1.77M2.64M1.34M2.34M834K1.55M
Interest Expense000000000000000--000
Other Income/Expense951K-13M462K-2.1M-850K2.17M129K1.03M2.54M1.49M3.52M2.8M3.29M3.68M1.77M2.64M1.34M2.34M834K1.55M
Pretax Income-31M-37.97M-35.09M-19.96M-30.48M-23.82M10.76M-36.05M-48.99M-60.57M-102.89M-120.77M21.33M-51.71M-53.13M-43.09M-43.92M-37.56M-47.6M-47.15M
Pretax Margin %-2149.45%-266.88%-6039.76%-109.03%-473.48%-315.49%21.78%-10127.53%-10185.24%-2966.06%-1094.84%-1766.93%13.5%-189.92%-200.77%-146.68%-155.57%-134.22%-166.66%-169.17%
Income Tax0-553K-161K27K119K-427K88K74K98K-272K1.27M-6.26M194K259K30K82K58K-67K86K24K
Effective Tax Rate %0%1.46%0.46%-0.14%-0.39%1.79%0.82%-0.21%-0.2%0.45%-1.23%5.19%0.91%-0.5%-0.06%-0.19%-0.13%0.18%-0.18%-0.05%
Net Income-31M-37.42M-34.93M-19.99M-30.6M-23.4M10.67M-36.13M-49.09M-60.3M-104.16M-114.51M21.13M-51.97M-53.16M-43.17M-43.98M-37.5M-47.69M-47.17M
Net Margin %-2149.45%-263%-6012.05%-109.18%-475.33%-309.84%21.6%-10148.31%-10205.61%-2952.74%-1108.35%-1675.29%13.38%-190.87%-200.89%-146.96%-155.78%-133.98%-166.96%-169.23%
Net Income Growth %-1.3%-59.94%-427.31%44.68%37.67%61.2%110.25%68.45%-332.29%-16.01%-95.96%-165.23%148.05%-38.61%-11.46%8.47%4.26%7.65%-2976.65%-31.28%
Net Income (Continuing)-31M-37.42M-34.93M-19.99M-30.6M-23.4M10.67M-36.13M-49.09M-60.3M-104.16M-114.51M21.13M-51.97M-53.16M-43.17M-43.98M-37.5M-47.69M-47.17M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.08-0.11-0.11-0.08-0.14-0.110.04-0.18-0.27-0.34-0.59-0.660.12-0.32-0.34-0.29-0.30-0.26-0.33-0.33
EPS Growth %42.86%0%-351.14%56.78%48.15%67.65%107.42%72.73%-325%-6.25%-73.53%-127.59%140%-23.08%-3.03%12.12%6.25%10.34%-2900%-26.92%
EPS (Basic)-0.08-0.11-0.11-0.08-0.14-0.110.05-0.18-0.27-0.34-0.59-0.660.13-0.32-0.34-0.29-0.30-0.26-0.33-0.33
Diluted Shares Outstanding389.62M337.73M304.27M256.95M220.27M210.19M214.32M203.95M180.34M177.62M177.17M174.32M169.18M164.72M158.04M148.16M146.22M145.74M145.4M143.98M
Basic Shares Outstanding389.62M337.73M304.27M256.95M220.27M210.19M208.34M203.95M180.34M177.62M177.17M174.32M168.53M164.72M156.34M148.16M146.22M145.74M145.4M143.98M
Dividend Payout Ratio--------------------